Grants Search Results

Based on progress to date, Dr. Rowe was awarded a new grant in 2019 to fund an additional year of this Fellow award. Leukemia that develops in infants under one year of age is difficult to cure and has poor long-term outcomes compared to leukemia developing in older children or teenagers. The therapies used for infant leukemia are highly toxic with long-term adverse effects and are not particularly effective at curing the disease. To identify more tolerable and more effective treatments, we need better models to study infant leukemia in the laboratory. We could use such a model to identify the genes that drive infant leukemia and make it so aggressive and challenging to treat, and to develop drugs to target these genes. Dr. Rowe has developed a new model of infant leukemia and is using this system to identify the key genes that make this form of leukemia so aggressive.

This grant funds a medical student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds an undergraduate student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds a medical student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds a medical student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds an undergraduate student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds an undergraduate student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds an undergraduate student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds a medical student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds a medical student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds an undergraduate student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds two undergraduate students to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds a doctoral student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds two students to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds a medical student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds a medical student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds two students to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

While deciphering the genetic code in pediatric cancers has illuminated important insights into their development, for the majority of these children, a matched targeted drug is not revealed. Dr. Stegmaier is working on an alternative solution to identify new, druggable Achilles heels in pediatric cancers. She is systematically eliminating each of 17,500 genes in 100 pediatric cancer cell models with innovative technology to determine whether loss of the gene is lethal. In parallel, Dr. Stegmaier and colleagues are screening these cells with over 4,000 drugs. Novel emerging targets/drugs will be validated in state-of-the-art pediatric cancer models with the ultimate deliverable of new pediatric cancer trials. The St. Baldrick's Robert J. Arceci Innovation Award is given in honor of the late Dr. Robert Arceci. A pioneer in the field, this award reflects Dr. Arceci's values including creativity, collaboration, and commitment to early- to mid-career scientists.

This grant funds a medical student to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.

This grant funds two students to complete work in pediatric oncology research for the summer. The experience may encourage them to choose childhood cancer research as a specialty.